NEA Management Company’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-5,736,363
| Closed | -$101M | – | 69 |
|
|
2021
Q3 | $101M | Hold |
5,736,363
| – | – | 1.2% | 11 |
|
|
2021
Q2 | $55.6M | Hold |
5,736,363
| – | – | 0.72% | 21 |
|
|
2021
Q1 | $61.6M | Hold |
5,736,363
| – | – | 1.38% | 20 |
|
|
2020
Q4 | $84.4M | Hold |
5,736,363
| – | – | 2.23% | 17 |
|
|
2020
Q3 | $81.5M | Hold |
5,736,363
| – | – | 3.45% | 12 |
|
|
2020
Q2 | $46.4M | Hold |
5,736,363
| – | – | 1.87% | 16 |
|
|
2020
Q1 | $23.2M | Buy |
5,736,363
+3,636,363
| +173% | +$14.7M | 1.21% | 18 |
|
|
2019
Q4 | $2.16M | Hold |
2,100,000
| – | – | 0.1% | 42 |
|
|
2019
Q3 | $646K | Hold |
2,100,000
| – | – | 0.05% | 45 |
|
|
2019
Q2 | $691K | Hold |
2,100,000
| – | – | 0.05% | 43 |
|
|
2019
Q1 | $1.39M | Buy |
2,100,000
+850,000
| +68% | +$561K | 0.07% | 44 |
|
|
2018
Q4 | $2.14M | Hold |
1,250,000
| – | – | 0.08% | 41 |
|
|
2018
Q3 | $7.25M | Hold |
1,250,000
| – | – | 0.31% | 37 |
|
|
2018
Q2 | $7.5M | Hold |
1,250,000
| – | – | 0.35% | 34 |
|
|
2018
Q1 | $9M | Hold |
1,250,000
| – | – | 0.4% | 32 |
|
|
2017
Q4 | $9.06M | Buy |
1,250,000
+200,000
| +19% | +$1.45M | 0.38% | 32 |
|
|
2017
Q3 | $5.41M | Hold |
1,050,000
| – | – | 0.19% | 35 |
|
|
2017
Q2 | $4.62M | Buy |
+1,050,000
| New | +$4.62M | 0.17% | 34 |
|